HIMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 263.5% based on the discounted cash flow analysis.
| Market cap | $7.54 Billion |
|---|---|
| Enterprise Value | $8.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.57 |
| Beta | 2.42 |
| Outstanding Shares | 231,746,126 |
| P/E Ratio | -55.38 |
|---|---|
| PEG | 18.28 |
| Price to Sales | 2.49 |
| Price to Book Ratio | 27.39 |
| Enterprise Value to Revenue | 3.34 |
| Enterprise Value to EBIT | -109.69 |
| Enterprise Value to Net Income | -61 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 5.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7482▼ 4.50% |
|---|---|
| Total Calls | 36,999,234▲ 3.11% |
| Total Puts | 27,684,034▼ 2.74% |
Holdings and activity of institutional investors.
| Ownership % | 69.16%▲ 3.39% |
|---|---|
| Total Invested | $5.48B▲ 76.93% |
| Investors Holding | 574▲ 86.00% |
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...